title: Cryptococcal infection associated with fludarabine therapy.
authors.forename: C S
authors.initials: CS
authors.lastname: Chim
authors.forename: R
authors.initials: R
authors.lastname: Liang
authors.forename: S S
authors.initials: SS
authors.lastname: Wong
authors.forename: K Y
authors.initials: KY
authors.lastname: Yuen
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D016516:CD4-CD8 Ratio; D003453:Cryptococcosis / Q000097:blood / Q000139:chemically induced*; D017809:Fatal Outcome; D016469:Fungemia / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D016867:Immunocompromised Host; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine